Holding(s) in Company
On October 15, 2025, Renalytix PLC received notification that UBS Group AG, specifically through UBS AG, crossed a threshold regarding major holdings. The event triggering the notification was an acquisition of voting rights. As of October 13, 2025, UBS AG holds 33,743,222 voting rights attached to shares, representing 8.324083% of the total voting rights in Renalytix PLC. This is an increase from the previously notified position of 5.200990%. The total number of voting rights held in the issuer is also 33,743,222, representing 8.324083%.
Select text to share a quote on X · sign in to keep highlights & notes in your RENX notes
- Reason for the notification (please mark the appropriate box or boxes with an "X")
| An acquisition or disposal of voting rights | X |
An acquisition or disposal of financial instruments
An event changing the breakdown of voting rights
Other (please specify) iii :
Details of person subject to the notification obligation iv
| Name | UBS Group AG - Investment Bank & Global Wealth Management |
| City and country of registered office (if applicable) | Z ürich Switzerland |
Full name of shareholder(s) (if different from 3.) v
| Name | UBS AG |
| City and country of registered office (if applicable) | London, United Kingdom |
| 5. Date on which the threshold was crossed or reached vi : | 13 October 2025 |
| 6. Date on which issuer notified (DD/MM/YYYY): | 15 October 2025 |
- Total positions of person(s) subject to the notification obligation
| Resulting situation on the date on which threshold was crossed or reached | 8.324083% | 0.000000% | 8.324083% | 33,743,222 |
| Position of previous notification (if applicable) | 5.200990% | 0.000000% | 5.200990% | |
| A: Voting rights attached to shares | ||||
| Class/type of shares ISIN code (if possible) | Number of voting rights ix | % of voting rights | ||
| Direct (DTR5.1) | Indirect (DTR5.2.1) | Direct (DTR5.1) | Indirect (DTR5.2.1) | |
| GB00BYWL4Y04 | 33,743,222 | 8.324083% | ||
| SUBTOTAL 8. A | 33,743,222 | 8.324083% | ||
B 1: Financial Instruments according to DTR5.3.1R (1) (a)
SUBTOTAL 8. B 1
B 2: Financial Instruments with similar economic effect according to DTR5.3.1R (1) (b)
SUBTOTAL 8.B.2
UBS Group AG
| UBS AG | 8.324083% | 8.324083% |
In case of proxy voting, please identify:
Name of the proxy holder
The number and % of voting rights held
The date until which the voting rights will be held
Additional information xvi
| Place of completion | Zurich, Switzerland |
|---|---|
| Date of completion | 15.10.2025 |
Cleaned text: letterheads, contacts and legal notices removed. View the original announcement ↗ · Company filings. Not investment advice.